Results 291 to 300 of about 64,386 (306)

Oral Cancer and Precancerous Lesions

Ca-A Cancer Journal for Clinicians, 2002
exaly  

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial

Lancet, The
Olivier Sanchez, Laurent Bertoletti, Isabelle Mahé   +2 more
exaly  

Risk of gastrointestinal bleeding with direct oral anticoagulants: a systematic review and network meta-analysis

The Lancet Gastroenterology and Hepatology, 2017
Nick Burr, Ruchit Sood, Aaron Corp
exaly  

DOACs: Direct oral Anticoagulants.

2023
openaire   +1 more source

Direct oral anticoagulants for postoperative myocardial injury

Lancet, The, 2018
Peter R Sinnaeve
exaly  

Oral Mucositis Complicating Chemotherapy and/or Radiotherapy: Options for Prevention and Treatment

Ca-A Cancer Journal for Clinicians, 2001
exaly  

Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial

Lancet, The
Eleni Korompoki, igor Sibon, Simon Fandler   +2 more
exaly  

Oral cavity and oropharyngeal squamous cell carcinoma—an update

Ca-A Cancer Journal for Clinicians, 2015
exaly  

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

Nature Reviews Drug Discovery, 2010
exaly  

7. Direct Oral Anticoagulants

2018
Allison E. Burnett, Candice L. Garwood
openaire   +1 more source